Staff Scientist IV and Tier 1 Research Chair in Inflammation and Fibrosis

Staff Scientist IV and Tier 1 Canada Research Chair in Inflammation and Fibrosis
Join to apply for the  Staff Scientist IV and Tier 1 Canada Research Chair in Inflammation and Fibrosis  role hael's Hospital .

The Keenan Research Centre for Biomedical Science at Unity Health Toronto, a research hospital fully affiliated with the University of Toronto, is currently seeking a full‑time, permanent Staff Scientist with an interest in inflammation and fibrosis research. The candidate will be expected to establish a conceptually innovative, competitive and independently funded basic research program relevant to the pathogenesis, prevention, treatment and/or resolution of fibrosis.

The Keenan Research Centre for Biomedical Science is located in a state‑of‑the‑art research facility containing outstanding core facilities accessible to all Keenan Scientists. Our 64 core researchers target common and high burden illnesses that are important to patients and strive to make discoveries that will improve patient’s lives.

Unity Health Toronto (Unity Health) invites applications for a full‑time, permanent Tier 1 Canada Research Chair (CRC) position to support a Canadian Institutes of Health Research (CIHR)-eligible research program in the areas of  inflammation and fibrosis . Research activities must align with one or more of the four pillars of world‑class research and innovation established in our Research Strategic Plan 2021‑2026.

This CRC position is open only to individuals external to Unity Health. The position will be located at the Keenan Research Centre for Biomedical Science located at 209 Victoria Street, Toronto, Ontario M5B 1X3.

Tier 1 Canada Research Chairs are tenable for seven years and renewable once. To meet the criteria of the program, the nominee must

be outstanding and innovative world‑class researchers whose accomplishments have made a major impact in their fields;

be recognized internationally as leaders in their fields;

have superior records of attracting and supervising graduate students and postdoctoral fellows (taking into account different practices in the relevant field or discipline) and, as chair holders, be expected to attract, develop and retain excellent trainees, students and future researchers;

be proposing an original, innovative research program of the highest quality.

Nominees for Tier 1 Chair positions must be full professors or associate professors who are expected to be promoted to the full professor level within one or two years of the nomination. Alternatively, if the candidate has been working outside the academic sector, nominees must possess the necessary qualifications to be appointed at these levels.

In cases where the nominee has non‑research commitments at Unity Health and/or at the University level (e.g., clinical or administrative), these commitments should be limited to allow the nominee to undertake their program of research at the level expected of a CRC holder. In addition, the nominee should not currently hold another major salary award, or the award should end before January 2024.

Further information about the Canada Research Chairs Program is on the Government of Canada’s CRC website.

In order to address the under representation of members of the four designated groups (women/gender minorities, members of visible minorities, persons with disabilities, and Indigenous peoples) in the CRC Program, all institutions are required to meet equity targets by 2029. In order to meet and maintain these targets, this call is only open to individuals who self‑identify in one of the four designated groups.

The Ideal Applicant Would Have

A PhD, MD or equivalent professional qualification;

Established leadership in the field of inflammation and fibrosis; this may be evidenced by influential publications in the field, a strong track record of obtaining peer‑reviewed funding, keynote invitations, leadership roles, participation as a thought leader in the field, among others;

A passion for translational research that will lead to patient impact;

Experience in patient/community engagement in their research;

Commitment to ensuring best practices of equity, diversity and inclusion, which…